Elanco Animal Health Incorporated is an animal health company delivering products and services to prevent and treat disease in farm animals and pets. The Company's product portfolio is sold in more than 90 countries and serves animals across many species, primarily dogs and cats (collectively, pet health) and cattle, poultry, swine, and sheep (collectively, farm animal). It has a diverse portfolio of products marketed under approximately 200 brands, including products for both pets and farm animals. The Company's global pet health portfolio is focused on parasiticides, vaccines and therapeutics. Its pet health products include Advantage Family, Atopica, Credelio Family, Drontal Family, Galliprant, Interceptor Plus, Milbemax, Onsior, Seresto, Trifexis, and TruCan. Its farm animal products include AviPro, Baytril, Catosal, Denagard, Experior, Hemicell, Maxiban/Monteban, Pulmotil, Rumensin, and Surmax. Its customers include consultants, veterinarians, farm animal producers and resellers.

Elanco Animal Health Inc プロフィール



企業コードELAN

会社名Elanco Animal Health Inc

上場日Sep 20, 2018

最高経営責任者「CEO」Simmons (Jeffrey N)

従業員数9000

証券種類Ordinary Share

決算期末Sep 20

本社所在地450 Elanco Circle

都市INDIANAPOLIS

証券取引所NASDAQ OMX NASDAQ Basic NYSE

国United States of America

郵便番号46221

電話番号18773526261

ウェブサイトhttps://www.elanco.com/

企業コードELAN

上場日Sep 20, 2018

最高経営責任者「CEO」Simmons (Jeffrey N)

Elanco Animal Health Incの経営陣



会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr. Jeffrey N. (Jeff) Simmons

President, Chief Executive Officer, Director

3.25M

+27.46%

Mr. Jeffrey N. (Jeff) Simmons

President, Chief Executive Officer, Director

3.25M

+27.46%

Mr. Jeffrey N. (Jeff) Simmons

President, Chief Executive Officer, Director

3.25M

+27.46%

Mr. David Kinard

Executive Vice President - Human Resources, Corporate Communications and Administration

229.43K

+10.35%

Mr. David Kinard

Executive Vice President - Human Resources, Corporate Communications and Administration

229.43K

+10.35%

Mr. David Kinard

Executive Vice President - Human Resources, Corporate Communications and Administration

229.43K

+10.35%

Mr. Lawrence Erik Kurzius

Independent Chairman of the Board

227.21K

+17.60%

Mr. Lawrence Erik Kurzius

Independent Chairman of the Board

227.21K

+17.60%

Mr. Lawrence Erik Kurzius

Independent Chairman of the Board

227.21K

+17.60%

Mr. Timothy J. (Tim) Bettington

Executive Vice President - Center of Strategic Growth

158.49K

+49.27%

詳細を見る

会社名

会社名/ポジション

ポジション

株式保有

変動額

Mr. Jeffrey N. (Jeff) Simmons

President, Chief Executive Officer, Director

3.25M

+27.46%

Mr. Jeffrey N. (Jeff) Simmons

President, Chief Executive Officer, Director

3.25M

+27.46%

Mr. Jeffrey N. (Jeff) Simmons

President, Chief Executive Officer, Director

3.25M

+27.46%

Mr. David Kinard

Executive Vice President - Human Resources, Corporate Communications and Administration

229.43K

+10.35%

Mr. David Kinard

Executive Vice President - Human Resources, Corporate Communications and Administration

229.43K

+10.35%

Mr. David Kinard

Executive Vice President - Human Resources, Corporate Communications and Administration

229.43K

+10.35%

よくある質問

Elanco Animal Health Incの上位5名の株主は誰ですか？



Elanco Animal Health Incの上位5名の株主は以下のとおりです。Mr. Jeffrey N. (Jeff) Simmons

Elanco Animal Health Inc（ELAN）の株式を保有している機関の数はいくつですか？



2026Q1時点で、Elanco Animal Health Incの株式を保有している機関は950社あり、保有株式の総市場価値は約549.30Mで、全体の109.98%を占めています。2025Q4と比較して、機関の持ち株は-60070109.00増加しています。

Elanco Animal Health Incの最大の収益源は何ですか？



2026Q1において、Pet Health部門がElanco Animal Health Incにとって最大の収益を生み出しており、その金額は718.00Mで、全収益の52.49%を占めています。